MacroGenics (MGNX)
(Real Time Quote from BATS)
$4.26 USD
-0.02 (-0.35%)
Updated Jul 10, 2024 01:32 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Bottom 32% (170 out of 250)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.73 | 1.69 | 9.99 |
Current Quarter Estimate | -0.75 | 5.88 | 61.00 |
Year Ago Quarter Estimate | -0.36 | 4.88 | 54.84 |
Next Quarter Estimate | -0.71 | 7.06 | 63.00 |
Next Year Estimate | -2.34 | 39.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -46.15 | 12.90 | 15.67 |
Next Year | 23.03 | 25.70 | 9.31 |
Last 5 Years | NA | 3.90 | 8.10 |
Next 5 Years | NA | 14.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -13.85 |
Price/Book (MRQ) | 2.52 | 1.95 |
Price/Cash Flow (MRFY) | NA | 10.88 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -53.60% | -7.07% |
Return on Equity (TTM) | -98.01% | 6.21% |
Debt to Equity (MRQ) | NA | 17.49 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.